Hanmi Pharm Publishes 'CSR Report'... Showcasing Achievements in Sustainable Innovation Management

[Asia Economy Reporter Lee Gwan-joo] Hanmi Pharmaceutical announced on the 15th that it has published a 'CSR Report' containing its sustainable innovation management goals and achievements on its official website.

Hanmi Pharmaceutical was the first in the domestic pharmaceutical industry to publish a CSR report in 2017, and has released the report five times including this one. This report formalizes cases of 'sustainable innovation management' under the company's core value of the spirit of 'creation and challenge.'

The report is organized by themes such as ▲ R&D management ▲ ethical management and compliance management ▲ talent management ▲ customer satisfaction management ▲ mutual growth and win-win management ▲ EHS (environment, health, and safety) management.

In particular, with the recent establishment of the Serious Accident Punishment Act and the strengthening of sentencing standards under the Industrial Safety and Health Act, regulations on safety and health have been tightened. Hanmi Pharmaceutical also strengthened activities for the safety of employees and suppliers, including the establishment of a dedicated safety and health team and the operation of a citizen disaster TF.

Woo Jong-su, CEO of Hanmi Pharmaceutical, said, “Hanmi Pharmaceutical is achieving steady growth every year based on unwavering R&D and sustainable management,” and added, “We will do our best to firmly establish the sustainable innovation management policy for a strong pharmaceutical nation and to position ourselves as a leading company in the pharmaceutical bio industry in the CSR and ESG fields.”

This content was produced with the assistance of AI translation services.